A recent study by Luo et al. demonstrated that in oxLDL-injured macrophages, micheliolide (MCL), an active metabolite of parthenolide, reduced both total and mtROS levels, increased SOD activity, improved mitochondrial function, modulated antioxidant responses and, importantly, reduced atherosclerosis. The gene discussed is SOD1; the disease is atherosclerosis.